EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigating the impact of antibiotic-induced dysbiosis on protection from Clostridium difficile colitis by mouse colonic innate lymphoid cells

Md Jashim Uddin iD, Brandon Thompson, Jhansi L Leslie, Casey Fishman, Katia Sol-Church, Pankaj Kumar, William A Petri iD

mBio · 2024

DOI: 10.1128/mbio.03338-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2024. Verfasst von Md Jashim Uddin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virgini…. Hauptthemen laut MEDLINE: Clostridioides difficile, Enterocolitis, Pseudomembranous, Clostridium Infections, Colitis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Innate lymphoid cells (ILCs) play a critical role in maintaining intestinal health in homeostatic and diseased conditions. During Clostridium difficile infection (CDI), IL-33 activates ILC2 to protect from colonic damage and mortality. The function of IL-33 and ILC is tightly regulated by the intestinal microbiota. We set out to determine the impact of antibiotic-induced disruption of the microbiome on ILC function. Our goal was to understand antibiotic-induced changes in ILC function on susceptibility to C. difficile colitis in a mouse model. We utilized high-throughput single-cell RNAseq to investigate the phenotypic features of colonic ILC at baseline, after antibiotic administration with or without IL-33 treatment. We identified a heterogeneous landscape of colonic ILCs with gene signatures of inflammatory, anti-inflammatory, migratory, progenitor, plastic, and antigen-presenting ILCs. Antibiotic treatment decreased ILC2 while coordinately increasing ILC1 and ILC3 phenotypes. Notably, Ifng + , Ccl5 + , and Il23r + ILC increased after antibiotics. IL-33 treatment counteracted the antibiotic effect by downregulating ILC1 and ILC3 and activating ILC2. In addition, IL-33 treatment markedly induced the expression of type 2 genes, including Areg and Il5. Finally, we identified amphiregulin, produced by ILC2, as protective during C. difficile infection. Together, our data expand our understanding of how antibiotics induce susceptibility to C. difficile colitis through their impact on ILC subsets and function. IMPORTANCE Clostridium difficile infection (CDI) accounts for around 500,000 symptomatic cases and over 20,000 deaths annually in the United States alone. A major risk factor of CDI is antibiotic-induced dysbiosis of the gut. Microbiota-regulated IL-33 and innate lymphoid cells (ILCs) are important in determining the outcomes of C. difficile infection. Understanding how antibiotic and IL-33 treatment alter the phenotype of colon ILCs is important to identify potential therapeutics. Here, we performed single-cell RNAseq of mouse colon ILCs collected at baseline, after antibiotic treatment, and after IL-33 treatment. We identified heterogeneous subpopulations of all three ILC subtypes in the mouse colon. Our analysis revealed several potential pathways of antibiotic-mediated increased susceptibility to intestinal infection. Our discovery that Areg is abundantly expressed by ILCs, and the protection of mice from CDI by amphiregulin treatment, suggests that the amphiregulin-epidermal growth factor receptor pathway is a potential therapeutic target for treating intestinal colitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridioides difficileEnterocolitis, PseudomembranousClostridium InfectionsColitisMiceAnimalsImmunity, InnateLymphocytesAnti-Bacterial AgentsInterleukin-33AmphiregulinDysbiosis

Stichwörter der Autor:innen

Clostridioides difficilecolitishost immune responseinnate lymphoid cellssingle-cell RNAseq

Substanzen

Anti-Bacterial AgentsInterleukin-33Amphiregulin

Autor:innen und Institutionen

  • Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
  • Arcus Biosciences, Hayward, California, USA.
  • Genome Analysis and Technology Core, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
  • Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, Virginia, USA.

ORCID-Profile: Md Jashim Uddin, William A Petri

Förderung

  • NIAID NIH HHS
  • HHS | National Institutes of Health

Zitieren

APA

Uddin, M. J., Thompson, B., Leslie, J. L., Fishman, C., Sol-Church, K., Kumar, P., & Petri, W. A. (2024). Investigating the impact of antibiotic-induced dysbiosis on protection from Clostridium difficile colitis by mouse colonic innate lymphoid cells. mBio. https://doi.org/10.1128/mbio.03338-23

Vancouver

Uddin MJ, Thompson B, Leslie JL, Fishman C, Sol-Church K, Kumar P, et al. Investigating the impact of antibiotic-induced dysbiosis on protection from Clostridium difficile colitis by mouse colonic innate lymphoid cells. mBio. 2024. doi:10.1128/mbio.03338-23

BibTeX
@article{Uddin2024,
  author = {Uddin, Md Jashim and Thompson, Brandon and Leslie, Jhansi L and Fishman, Casey and Sol-Church, Katia and Kumar, Pankaj and Petri, William A},
  title = {Investigating the impact of antibiotic-induced dysbiosis on protection from Clostridium difficile colitis by mouse colonic innate lymphoid cells},
  journal = {mBio},
  year = {2024},
  doi = {10.1128/mbio.03338-23}
}
Kostenlos starten →